88 stocks hit fresh 52-wk highs! Stars are aligning favourably for bull market on Dalal Street

ET Markets Daily Brief | Fri, Jun 03, 2016 | 04:26 PM IST Follow ET Markets

Market@ 2016 high: DII-heavy stocks make merry, retail bets prove wrong Media reports on Friday suggested the flagship company of the Jaypee group has defaulted on bank loans, interest and statutory payments of Rs 4,539 crore. Ujjivan, Equitas, Infosys among 88 stocks that hit fresh 52-week highs The bulls failed to push Nifty50 beyond its key resistance level placed around 8240-8250 which is also its 61.8 retracement level from 9,119 high levels. Here's what happened on Dalal Street all through Friday If you are reading this, chances are the Sensex and the Nifty are part of your daily life, and actions on Dalal Street can make or mar your day.

Interview One to One It is very important that the monsoon plays out well, says Shobhit Mehrotra, Senior Fund Manager & Head of Credit, HD...

Advertorial How and when to de-risk one's investment portfolio As one nears long-term goals, it is important to preserve the accumulated wealth through the process of de-risking. Read on to find out how and when de-risking helps in the financial planning process.

Market Watch 3 Jun | 04:26PM| SENSEX NIFTY USD/INR GOLD 26843.03 ↓-0.11 8220.80 ↑1.85 67.33 ↑0.04 28611.00 ↑20.00

Gainers Losers 3 Jun, 2016, 04:26PM IST, PTI|View All Company Name Live Price Change (%) Volume High Low Jyoti Resins & Adhesives Ltd. 130.60 19.93 21339 130.65 108.35 Shree Precoated Steels Ltd. 2.85 19.25 53469 2.86 2.40 Dharani Sugars & Chemicals Ltd. 46.95 18.56 126849 47.50 42.10

Tweet of the day... F&O view: Nifty50 eyes 8,400 level; 10 stocks with most long buildups

FROM THE NEWSPAPER

Stars are aligning favourably for bull market on Dalal Street; here's how! Domestic equities, as well as currency, have shown resilience at a time when most emerging markets corrected sharply. India is showing signs of decoupling. Pharma can be a contra bet; 5 stocks global brokerages are positive on Increasing concerns over USFDA and a slowdown in the US business can well hurt Indian pharma in the near term, which can in turn weigh on margins and sales. Five technical charts which show Nifty50 heading for a new record The bulls are building the momentum, which is pushing the domestic market to a fresh record high. The index has seen a strong upward move of over 500 points. For the first time in history, India will not have power deficit situation in FY17 The country will have a surplus of 3.1% during peak hours and 1.1% during non-peak hours during 2016-17, latest data shows. Mark Mobius puts his bets on India's small-cap stocks The smaller cos may climb after trailing the rally in the biggest shares as benefits from PM Modi's growth-boosting measures take hold, he said.

MORE LINKS:Gainers|Losers|Movers|Only Buyers|Only Sellers|Surging Volumes|Indices

More Newsletters

Daily Newsletter Special stories that round up the major developments of the day

ET Mutual Fund A weekly round-up of the top news and views from the mutual fund industry

ET Investment Opportunities Property, Stocks, IPOs, NFOs, Mutual Funds and latest investment options in your inbox

Wealth Weekly news on personal finance, stocks, property, gold, tax planning and more

View All

Follow ET Markets

About us|Advertise with us|Feedback|Sitemap|Code of Ethics © 2016 Times Internet Limited.

To ensure delivery directly to your inbox, please add etnotifications@indiatimes.com to your address book today. If you are having trouble viewing this newsletter, please click here

To unsubscribe or edit your subscriptions please click here